Published, presented and verified.

Anpac Bio has partnered with respected medical and research institutions, in China and the U.S., conducting multiple research studies.

Anpac Bio Abstract-Evaluation of a Multi-Level, Multi-Parameter Detection Method for Digestive System Cancer Diagnosis

Anpac-Bio-Abstract-Evaluation-of-a-Multi-Level-Multi-Parameter-Detection-Method-for-Digestive-System-Cancer-Diagnosis

Anpac Bio Abstract-Investigations of a New Diagnostics Technology for Hepatocellular Carcinoma Screening

Anpac-Bio-Abstract-Investigations-of-a-New-Diagnostics-Technology-for-Hepatocellular-Carcinoma-Screening

Anpac Bio Abstract-Investigations of an Improved Esophageal Cancer Diagnostics Approach

Anpac-Bio-Abstract-Investigations-of-an-Improved-Esophageal-Cancer-Diagnostics-Approach

Anpac Bio Abstract-Investigations of Breast Cancer Screening Using a Novel In Vitro Diagnostics Technology

Anpac-Bio-Abstract-Investigations-of-Breast-Cancer-Screening-Using-a-Novel-In-Vitro-Diagnostics-Technology

Anpac Bio Abstract-Investigations on Non-Small Cell Lung Cancer Screening

Anpac-Bio-Abstract-Investigations-on-Non-Small-Cell-Lung-Cancer-Screening

Anpac Bio Abstract-Cancer differentiation analysis technology as a novel technology for cerebral cancer screening.

Cancer-differentiation-analysis-technology-as-a-novel-technology-for-cerebral-cancer-screening

Founded in 2008, Anpac Bio-Medical Science Co., Ltd. is drawing on expertise.

A cross disciplinary team.

Cancer Research & Detection

Chemistry & Bio-chemistry

Nano-technology & Physics

Surface & Material Science

Engineering & Manufacturing

“game changing”

CDA technology is called “game-changing” in Nobel Prize Laureate Summit on Biomedical Science (NPLS) publications.

Read the full article
©2019 Anpac Bio-Medical Science Co., Ltd.
;